
|Articles|October 1, 2003
FDA EXPANDS CLEARANCE FOR CANDELA LASER
The U.S. Food and Drug Administration (FDA) has given expanded wrinkle clearance to Candela Corp. for its Smoothbeam diode laser, which can be used for non-invasive treatment of facial wrinkles.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
2
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Phase 2 Nemolizumab Trial Opens for CPUO
5


















